Barclays Maintains Overweight on MasTec, Lowers Price Target to $320
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
Barclays analyst Adam Seiden maintains MasTec (NYSE:MTZ) with a Overweight and lowers the price target from $340 to $320.
Barclays analyst Adam Seiden maintains MasTec (NYSE:MTZ) with a Overweight and lowers the price target from $340 to $320.